Pharmacogenetic Impact of CYP2C19 Variants on Diazepam Treatment Outcomes in Alcohol Withdrawal Syndrome.

Selin Özkan-Kotiloğlu; Kenan Can Tok; Mustafa Danışman; Mukaddes Asena Yıldırım; Ceren H Bozmaoğlu; Mehmet Gumustas; İnci Özgür-İlhan; Özlem Doğan; H Sinan Süzen; Dilek Kaya-Akyüzlü

doi:10.1007/s12035-026-06282-0

SCHEDA SCIENTIFICA2026Altra ricerca

Pharmacogenetic Impact of CYP2C19 Variants on Diazepam Treatment Outcomes in Alcohol Withdrawal Syndrome.

Selin Özkan-Kotiloğlu, Kenan Can Tok, Mustafa Danışman, Mukaddes Asena Yıldırım, Ceren H Bozmaoğlu, Mehmet Gumustas, İnci Özgür-İlhan, Özlem Doğan, H Sinan Süzen, Dilek Kaya-Akyüzlü

Molecular neurobiology · 2026

Psicologia clinica Psicoterapia

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansCytochrome P-450 CYP2C19MaleDiazepamSubstance Withdrawal SyndromeFemaleTreatment OutcomePharmacogenomic VariantsAdultMiddle AgedGenotypePharmacogeneticsCYP2C19Alcohol withdrawal syndromePolymorphismrs12248560rs4244285

Come citare questo studio

Selin Özkan-Kotiloğlu, Kenan Can Tok, Mustafa Danışman, Mukaddes Asena Yıldırım, Ceren H Bozmaoğlu, Mehmet Gumustas, İnci Özgür-İlhan, Özlem Doğan, H Sinan Süzen, Dilek Kaya-Akyüzlü. (2026). Pharmacogenetic Impact of CYP2C19 Variants on Diazepam Treatment Outcomes in Alcohol Withdrawal Syndrome.. Molecular neurobiology. DOI: 10.1007/s12035-026-06282-0

Consulta la pubblicazione originale ↗